Business Wire

Mentice, Together with the ASSERT Centre at University College Cork, Ireland, to Introduce State-of-the-Art Training Solution for Acute Ischemic Stroke (AIS)

Jaa

The ASSERT Centre at University College Cork in Ireland is to host a new mechanical thrombectomy training course featuring Mentice’s high-fidelity endovascular training solution. The training solution is the result of a project part-financed by Vinnova, Sweden’s national innovation agency.

ASSERT (Application of Science to Simulation-based Education and Research on Training) plans to hold the two-day course June 29-30. The course combines high-fidelity simulators from Mentice with a ‘proficiency-based progression’ training method.

“This method,” says Mentice CEO Göran Malmberg, “brings system generated objective assessment into the training process. Trainees must demonstrate proficiency in a series of carefully selected training milestones before progressing. These milestones are assessed by the system which makes them entirely objective. It’s a critical development, the number of endovascular interventions for stroke is set to rise dramatically worldwide. Proficiency-based progression with simulation based structured training will not only help to radically reduce the cost of skills development but also help scale this procedure in a safe way.”

Mechanical thrombectomy—a revolutionary new minimally invasive procedure in which a clinical device is introduced into the affected brain’s vasculature to mechanically remove a blood clot—is now recognized as the preferred treatment for acute ischemic stroke. “The shift to interventional treatment of stroke is a fantastic health opportunity that will have the ability to save hundreds of thousands of patients annually worldwide,” comments Malmberg. “This promising procedure will face a multitude of challenges including early diagnosis of stroke and of course effective dispatch of patients to treatment. In addition, effective training of new and existing teams and operators is certainly one big challenge of a safe roll-out, which is where Mentice, ASSERT and proficiency-based progression can really contribute.”

The Mentice training solution deployed by ASSERT has been developed in collaboration with recognized neurovascular specialists Professor Thomas Liebig, Dr. Markus Holtmannspötter and Dr. Robert Crossley, as well as with technology-enhanced learning expert Professor Tony Gallagher of ASSERT.

“Mechanical Thrombectomy for acute stroke,” says Professor Tony Gallagher of ASSERT, “is a life-changing treatment for many gravely ill patients. The success of the treatment is determined in no small part by the skills of the clinician performing the procedure.”

A larger panel with more than 20 experts from 7 countries have been highly involved in validating this new training method which will be shown for the first time during this two-day course, June 29-30.

“We are privileged to have the course facilitated by leading neurovascular specialists at the ASSERT Centre and are confident that this program will be the first of many,” says ASSERT Director/Clinical Lead Professor Barry O’Reilly.

About Mentice

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment opportunities. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a safe environment within the fields of endovascular intervention and minimally invasive surgery. The advantages of training with Mentice solutions are well documented enhancing clinical performance, reducing cost, and, in the long term, improving patient safety. For more information please visit www.mentice.com

About ASSERT

The ASSERT Centre, College of Medicine and Health, University College Cork Ireland is a new state of the art facility dedicated to cadaveric and simulation based healthcare training and research. ASSERT provides both the facility and services ideally suited to conducting all types of training for healthcare practitioners, specialists or teams. ASSERT is ideally placed as the bridge that links clinicians, industry and healthcare research institutes both locally and internationally. For more information, please see www.ucc.ie/assert

Contact information

Mentice AB
Hiral Chavda, Marketing Communications Manager
+46 (0) 31 339 94 94
hiral.chavda@mentice.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Yokogawa Develops N-IO Standard Field Enclosure and Control System Virtualization Platform18.12.2017 05:00Tiedote

Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed an N-IO standard field enclosure and a control system virtualization platform. The enclosure is a weatherproof remote IO cabinet that stores IO devices used by the CENTUM(R) VP integrated production control system and the ProSafe(R)-RS safety instrumented system, and the virtualization platform enables the control of multiple virtual devices on a single server. By reducing the amount of time and effort to engineer a new system, these solutions help to both speed up project execution and reduce total cost of ownership (TCO). The N-IO standard field enclosure is scheduled to be released in February 2018, and the virtualization platform will be released in May 2018. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171217005010/en/ N-I

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar16.12.2017 01:13Tiedote

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 15:34Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 15:21Tiedote

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 14:38Tiedote

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 14:00Tiedote

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme